Registration
 
All news
Top Stories
Editors' Picks
Crypto
Financial News
Currencies
Market Voices
Companies
Regulators
Central Banks
Daria Chernytska
Daria Chernytska

Verastem, Inc. releases Q4 and year end 2025 results with business update

Verastem, Inc. releases Q4 and year end 2025 results with business update
Verastem, Inc. posts 2025 results

Verastem, Inc. has announced its fourth quarter and year end 2025 financial results along with updates on its business operations.

The company also shared insights into the progress of its RAS/MAPK pathway driven pipeline programs and ongoing product launches. Further details can be found in the official press release.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Editor's Picks for You

Intel's comeback: Apple, Trump and the AI bet
  • By Mikhail Vnuchkov
  • 20 hours ago
Intel's comeback: Apple, Trump and the AI bet
Editors' Picks
Bitcoin price prediction based on RSI: Is BTC poised for a new rally?
  • By Oleg Tkachenko
  • Yesterday
Bitcoin price prediction based on RSI: Is BTC poised for a new rally?
Editors' Picks
Toncoin becomes Gram: Why Durov restored token's original name
  • By Anastasiia Chabaniuk
  • 16.06.2026
Toncoin becomes Gram: Why Durov restored token's original name
Editors' Picks
All Editors' Top Picks

Latest Verastem News

Verastem, Inc. initiates first dosing in Phase 2 trial for KRAS G12D pancreatic cancer therapy
  • By Parshwa Turakhiya
  • 17.06.2026
Verastem, Inc. initiates first dosing in Phase 2 trial for KRAS G12D pancreatic cancer therapy
Companies
#Verastem
Verastem, Inc. plans conference to unveil progress on KRAS G12D trial
  • By Andrey Mastykin
  • 15.06.2026
Verastem, Inc. plans conference to unveil progress on KRAS G12D trial
Companies
#Verastem
Verastem, Inc. receives U.S. FDA fast track for KRAS G12D inhibitor in NSCLC treatment
  • By Mikhail Vnuchkov
  • 03.06.2026
Verastem, Inc. receives U.S. FDA fast track for KRAS G12D inhibitor in NSCLC treatment
Companies
#Verastem
All Verastem News
  • Mikhail Vnuchkov
  • 20 hours ago
Intel's comeback: Apple, Trump and the AI bet
  • Oleg Tkachenko
  • Yesterday
Bitcoin price prediction based on RSI: Is BTC poised for a new rally?
  • Anastasiia Chabaniuk
  • 16.06.2026
Toncoin becomes Gram: Why Durov restored token's original name
  • Kyle Torpey
  • 15.06.2026
Why Tether flipping Ethereum is a pivotal moment for crypto
  • Eugene Komchuk
  • 15.06.2026
MiCA deadline: Why crypto companies are leaving Europe
  • Daria Chernytska
  • 20 min ago
Brian Armstrong: Coinbase unveils pre-IPO perps, stock options, tokenized stocks in everything exchange
  • Andreas Kristo
  • 40 min ago
Harvard Business School faculty list Volatility Machine for summer 2026, Michael Pettis writes
  • Elena Nikulina
  • 50 min ago
Terrorist groups could receive $324 billion, Mark R. Levin warns
  • Hanna Syniavska
  • 1 hour ago
TIME suggested retiring 401k in 2009, Ryan Detrick adds
  • Andrey Mastykin
  • 1 hour ago
Company dominance fluctuates through cycles and bubbles, Callum Thomas notes
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.
Top News
  • Olga Shendetskaya
  • 13 hours ago
Goldman sees Warsh remarks as new risk for two-year Treasuries
Goldman sees Warsh remarks as new risk for two-year Treasuries
  • Andrey Mastykin
  • 14 hours ago
G7 calls for stronger fight against North Korean crypto theft
G7 calls for stronger fight against North Korean crypto theft
  • Eugene Komchuk
  • 15 hours ago
First oil tankers cross Strait of Hormuz after U.S.-Iran agreement
First oil tankers cross Strait of Hormuz after U.S.-Iran agreement
  • Ivan Andriyenko
  • 19 hours ago
U.S. futures rise as investors weigh Iran deal and Fed
U.S. futures rise as investors weigh Iran deal and Fed
  • Mikhail Vnuchkov
  • 20 hours ago
Intel's comeback: Apple, Trump and the AI bet
Intel's comeback: Apple, Trump and the AI bet
Live News
  • Anton Kharitonov
  • Now
Microsoft balances AI investment with investor expectations
  • Anton Kharitonov
  • Now
Apple maintains strong fundamentals despite market pressures
  • Mykhailo Ihnatenko
  • Now
SPCX pulls back for the first time: Can SpaceX optimism sustain rally?
  • Anton Kharitonov
  • Now
Bitcoin tests major support after hawkish Fed signal
  • Mykhailo Ihnatenko
  • Now
Intel jumps on Apple foundry hopes: Can INTC reach new highs?
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org World Association of News Publishers https://gdpr.eu/ GDPR